These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2752907)

  • 1. Susceptibility of clinical isolates to dactimicin and gentamicin.
    Bergan T
    Drugs Exp Clin Res; 1989; 15(3):109-12. PubMed ID: 2752907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of dactimicin in vitro compared with that of dibekacin, netilmicin, sisomicin and micronomicin.
    Inouye S; Hara T; Matsuhashi Y; Kitasato I
    Drugs Exp Clin Res; 1989; 15(10):455-63. PubMed ID: 2632214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes.
    Felmingham D; Jones K
    Drugs Exp Clin Res; 1989; 15(3):133-6. PubMed ID: 2752913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of dactimicin against aerobic and anaerobic bacteria isolated from intra-abdominal infections.
    Nord CE; Kager L
    Drugs Exp Clin Res; 1989; 15(3):113-4. PubMed ID: 2752908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M; Brun Y; Forey F; Fleurette J
    Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of netilmicin and cefotaxime compared to that of other aminoglycosides.
    Shah PM; Belve V
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):285-8. PubMed ID: 552591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro study of dactimicin (ST 900) against methicillin-susceptible and -resistant staphylococci.
    Stefani S; Mezzatesta M; Oliveri S; Nicolosi VM; Russo G
    Chemioterapia; 1987 Aug; 6(4):264-8. PubMed ID: 3652276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro bactericidal activity and post-antibiotic effect of dactimicin, a new aminoglycoside, alone and in combination with other antibiotics.
    Debbia EA; Schito GC; Stefani S; Nicoletti G
    Drugs Exp Clin Res; 1989; 15(3):125-8. PubMed ID: 2752911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dactimicin, a new, less toxic aminoglycoside antibiotic active against resistant bacteria.
    Omoto S; Yoshida T; Kurebe M; Inouye S
    Drugs Exp Clin Res; 1987; 13(12):719-25. PubMed ID: 3447874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
    Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS
    J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estimation of level of aminoglycosides susceptibility of bacterial strains isolated from patients with systemic and general infections].
    Kowalska-Krochmal B; Dolna I; Dobosz A; Wrzyszcz E; GoĊ›ciniak G
    Med Dosw Mikrobiol; 2008; 60(3):205-14. PubMed ID: 19143174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics.
    Weinstein RA; Nathan C; Delzell D; Kabins SA
    Chemioterapia; 1987 Oct; 6(5):315-8. PubMed ID: 3123078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of dactimicin in the treatment of experimentally induced intra-abdominal infections.
    Nord CE; Lahnborg G
    Drugs Exp Clin Res; 1989; 15(3):115-8. PubMed ID: 2752909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of bacterial resistance to five aminoglycosides. A study of 3,354 strains isolated in a hospital milieu].
    Fourche J; Texier-Maugein J; Mormede M
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):665-70. PubMed ID: 3054744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults.
    Salmon SA; Watts JL
    Avian Dis; 2000; 44(1):85-98. PubMed ID: 10737648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
    King A; Phillips I
    Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First microbiological approach to dactimicin, a novel aminoglycoside antibiotic.
    Stefani S; Nicoletti G; Russo G; Toscano MA
    Drugs Exp Clin Res; 1987; 13(12):727-9. PubMed ID: 3447875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.